News & Updates

Deprescribing in older patients boosts appropriateness, reduces cost of drug use

08 Oct 2020

Deprescribing interventions in older patients with life-limiting illness (LLI) and limited life expectancy (LLE) may improve medication appropriateness and has potential for enhancement of several clinical outcomes and cost savings, suggests a study.

Deprescribing in older patients boosts appropriateness, reduces cost of drug use

08 Oct 2020

Detection of dysfunctional pancreatic beta cells in T1D feasible with GLP-1R imaging

07 Oct 2020 by

Exendin-4 imaging targeting GLP-1* receptor (GLP-1R) ably detects residual, dysfunctional pancreatic beta cells in individuals with long-standing type 1 diabetes (T1D), according to a study presented at EASD 2020. This breakthrough brings research closer to the possibility of restoring insulin-producing cells depleted in T1D.

Detection of dysfunctional pancreatic beta cells in T1D feasible with GLP-1R imaging

07 Oct 2020

Stopping long-term mepolizumab may lead to exacerbations, loss of asthma control

07 Oct 2020 by

In patients with severe eosinophilic asthma, cessation of mepolizumab may lead to increased exacerbations and reductions in asthma control, according to results of the COMET* trial.

Stopping long-term mepolizumab may lead to exacerbations, loss of asthma control

07 Oct 2020

Increased toxicity seen in women receiving adjuvant chemo for colon cancer

07 Oct 2020

Female patients with colon cancer experience significantly greater toxicity with adjuvant chemotherapy compared with their male counterparts, a study has found.

Increased toxicity seen in women receiving adjuvant chemo for colon cancer

07 Oct 2020

Low adherence to febrile neutropaenia guidelines leads to hospitalization, over-prescription

07 Oct 2020

A recent study has found low adherence to the febrile neutropaenia guidelines, which results in unnecessary hospital admissions of low-risk patients and over-prescription of empirical vancomycin.

Low adherence to febrile neutropaenia guidelines leads to hospitalization, over-prescription

07 Oct 2020

Longer dosing period with mirikizumab for UC may induce response in initial nonresponders

07 Oct 2020

Administering extended doses of mirikizumab for an additional 12 weeks successfully produces a clinical response in up to 50 percent of ulcerative colitis (UC) patients who did not benefit from 12 weeks of induction doses, according to the results of a phase II trial.

Longer dosing period with mirikizumab for UC may induce response in initial nonresponders

07 Oct 2020

BEACON CRC: Strategies to manage treatment-related AEs

06 Oct 2020 by

Several strategies have been proposed to help manage the adverse events (AEs) that emerged during the BEACON CRC trial which assessed the effect of encorafenib plus cetuximab in patients with BRAF V600E mutant metastatic colorectal cancer (mCRC) who had progressed after one or two prior regimens.

BEACON CRC: Strategies to manage treatment-related AEs

06 Oct 2020

Infliximab reverses clotting abnormalities in IBD patients

06 Oct 2020

Treatment with infliximab to control inflammation effectively reduces parameters that are associated with a higher risk of venous thromboembolism in patients with inflammatory bowel disease (IBD), results of a study have shown.

Infliximab reverses clotting abnormalities in IBD patients

06 Oct 2020

Which mask type is most effective for handling anticancer drug?

06 Oct 2020

Measurement of the leak rate of masks used in anticancer drug handling confirms a significant difference, with the cup-type activated carbon mask showing effectiveness based on its low leak rate, suggest the results of a study.

Which mask type is most effective for handling anticancer drug?

06 Oct 2020

Teneligliptin a safe and effective treatment option for T2DM

06 Oct 2020

In patients with type 2 diabetes mellitus (T2DM) inadequately controlled with diet and exercise, teneligliptin presents a safe and effective way of disease control, a recent study has found.

Teneligliptin a safe and effective treatment option for T2DM

06 Oct 2020

News & Updates

Filter by Specialty:

Specialty:

Deprescribing in older patients boosts appropriateness, reduces cost of drug use

Deprescribing in older patients boosts appropriateness, reduces cost of drug use

Detection of dysfunctional pancreatic beta cells in T1D feasible with GLP-1R imaging

Detection of dysfunctional pancreatic beta cells in T1D feasible with GLP-1R imaging

Stopping long-term mepolizumab may lead to exacerbations, loss of asthma control

Stopping long-term mepolizumab may lead to exacerbations, loss of asthma control

Increased toxicity seen in women receiving adjuvant chemo for colon cancer

Increased toxicity seen in women receiving adjuvant chemo for colon cancer

Low adherence to febrile neutropaenia guidelines leads to hospitalization, over-prescription

Low adherence to febrile neutropaenia guidelines leads to hospitalization, over-prescription

Longer dosing period with mirikizumab for UC may induce response in initial nonresponders

Longer dosing period with mirikizumab for UC may induce response in initial nonresponders

BEACON CRC: Strategies to manage treatment-related AEs

BEACON CRC: Strategies to manage treatment-related AEs

Infliximab reverses clotting abnormalities in IBD patients

Infliximab reverses clotting abnormalities in IBD patients

Which mask type is most effective for handling anticancer drug?

Which mask type is most effective for handling anticancer drug?

Teneligliptin a safe and effective treatment option for T2DM

Teneligliptin a safe and effective treatment option for T2DM